Bayer, MSN Labs Seek To Drop Drug IP Fight Midtrial
Three days into a virtual bench trial in Delaware federal court, Bayer AG and MSN Laboratories on Friday proposed to end their legal fight over MSN's plans to market a generic...To view the full article, register now.
Already a subscriber? Click here to view full article